RPRX
Royalty Pharma plc Class A Ordinary SharesData: 2026-10-22
Quick Stats
Oct 22, 202643.9
AI Score
HOLD0.93
Volume Ratio
Nov 04, 2026
Next Earnings
15
+ve Days (30d)
14
-ve Days (30d)
RPRX Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
RPRX Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
RPRX Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RPRX Daily Out of Money Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RPRX Daily In the Money Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RPRX Most Active Options by Volume(near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RPRX Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RPRX Stock Summary
Last updated Oct 22, 2026
RPRX is currently trading at $63.75, positioned above its 200-day moving average of $52.48, indicating a long-term uptrend. The stock has a 52-week range of $35.915 to $64.38.
Technical Analysis: The 50-day moving average stands at $59.61, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 70.182, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.124, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RPRX at 43.9/100 with a HOLD recommendation.
RPRX (Royalty Pharma plc Class A Ordinary Shares) Indicators
Last updated Oct 22, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 70.182 |
| CMF (20) | 0.124 |
| ROC (10) | 13.414 |
| ADX (14) | 29.88 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.865 |
| AROONOSC (14) | 71.429 |
| WILLAMS %R (14) | -1.033 |
| MFI (14) | 66.216 |
RPRX Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Oct 21 | Gravestone Doji | Bullish | 55.2% | +2.2 pts | 21200 |
| Oct 15 | Gravestone Doji | Bullish | 55.2% | +2.2 pts | 21200 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Royalty Pharma plc Class A Ordinary Shares is above both the 50 Day and 200 Day SMA which is considered Bullish.
RPRX Moving Averages Analysis
Royalty Pharma plc Class A Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Oct 22, 2026
Royalty Pharma plc Class A Ordinary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 22, 2026
RPRX (Royalty Pharma plc Class A Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Oct 22, 2026
| Days | MA |
|---|---|
| 10 | 59.93 |
| 20 | 58.66 |
| 30 | 58.6 |
| 50 | 59.61 |
| 100 | 58.13 |
| 200 | 52.48 |
RPRX Fundamental Analysis
| P/E (Forward) | 29.4118 |
| P/E (Trailing) | 33.0585 |
| Market Cap ($) | 35.9 billion |
| Earnings/Share ($) | 1.88 |
| Net Profit Margin (%) | 0.3202 |
| Dividend/Share ($) | 0.91 |
| EPS Estimate Current Year ($) | 5.3214 |
| EPS Estimate Next Year ($) | 5.799 |
| WallStreet Target Price ($) | 65.38 |
| Most Recent Quarter |
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.